We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

hp

Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Advertise with Us

GLOBE SCIENTIFIC, LLC

EUROIMMUN AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products:

All-in-one Molecular Diagnosis System

All-in-one Molecular Diagnosis System

Automatic Nucleic Acid Extractor

Portable ATP Monitoring System

Real-time PCR System

More products

Merck Life Science KGaA

GC Medical Science corp.

Featured Whitepaper

Boule Diagnostics AG:
Slide preparation for WBC differential by manual microscopy

Download Mobile App

Featured Video

ADLM:
ADLM 2025 – Bring the wonder to the premier global laboratory medicine conference

DIASYS DIAGNOSTIC SYSTEMS

Meet TianLong at the 73rd Annual Convention of Philippine Society of Pathologist

By LabMedica International staff writers
Posted on 22 Apr 2024

We are excited to announce that TianLong and KHB will be participating in the 73rd Annual Convention of Philippine Society of Pathologist. More...

We will be gathering at the Hotel Shangri-La, Makati from 25 to 27 April, come and meet us in person at our BOOTH Platinum #7!

The Annual Convention of PSP undertakes a series of seminars, symposia and exhibitions, for improving quality patient care with assurance of quality laboratory output. These activities are now the mainstay of the current thrust to upgrade both manpower and institutional developments of the country.

Mark the calendar, see you next week in the Philippines!

Booth: Platinum #7

Date: April 25 to 27

Venue: Shangri-La, Makati

Learn more:

https://www.medtl.net/

#IVD #PCR #Health #MolecularDiagnostics #GeneticTesting

Visit expo >

Gold Member

Pharmacogenetics Panel

VeriDose Core Panel v2.0

3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler

New

Myocardial Infarction Test

Finecare cTn I/NT-proBNP Rapid Quantitative Test

New

Droplet Digital PCR System

QX600 AutoDG

Read the full article by registering today, it's FREE!

It's Free!

Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.

Free digital version edition of LabMedica International sent by email on regular basis
Free print version of LabMedica International magazine (available only outside USA and Canada).
Free and unlimited access to back issues of LabMedica International in digital format
Free LabMedica International Newsletter sent every week containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!

Sign in: Registered website members

Sign in: Registered magazine subscribers

Latest Focus News

Channels

Clinical Chemistry

view channel

Image: New research has linked skin barrier dysfunction to pediatric eosinophilic esophagitis (Photo courtesy of 123RF)

Simple Skin Test Could Revolutionize Diagnosis of Pediatric Eosinophilic Esophagitis

Eosinophilic esophagitis (EoE) is a chronic, food allergen-driven condition marked by inflammation and damage to the esophageal lining. Diagnosing EoE in children remains a clinical challenge, especially... Read more

Image: A new diagnostic tool shines a powerful new light into the viral darkness (Photo courtesy of Adobe Stock)

Portable Diagnostic Tool Uses Bioluminescence to Detect Viruses at POC

Point-of-care diagnostics have become crucial tools in many households, enabling individuals to measure blood sugar, conduct pregnancy tests, and even perform their own COVID-19 assays. These diagnostics... Read more

Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel

Image: PhD researcher Olivia Moscatelli and Associate Professor Jason Tye-Din with the highly sensitive technology used to detect the critical IL-2 signal (Photo courtesy of WEHI)

Groundbreaking Blood Test Detects Celiac Disease in Patients Without Gluten Exposure

Getting a reliable diagnosis for coeliac disease has long required patients to endure weeks of consuming gluten—a painful process for many already following gluten-free diets. Now, a groundbreaking blood... Read more

Image: The platform can detect bacterial STIs, urinary tract infections and viral infections in just five minutes (Photo courtesy of Linear Diagnostics)

Low-Cost Near-Patient Diagnostic Platform Rapidly Diagnoses STIs

Every day, over one million sexually transmitted infections (STIs) are acquired worldwide. Rapid diagnosis and appropriate antibiotic treatment are crucial to control their spread. Timely testing is necessary... Read more

Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

World’s First AI-Powered Tool to Transform Type 1 Diabetes Diagnosis and Treatment

For years, testing for Type 1 Diabetes (T1D) has relied on symptoms and biomarkers that typically become evident only at the disease’s onset, making early detection difficult. This is particularly concerning... Read more

Hematology

view channel

Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Image: The FINDER multifunctional testing platform can run multiple types of tests and deliver rapid results for near-patient use (Photo courtesy of Baebies)

First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes

Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more

Image: The 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia (Photo courtesy of 123RF)

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more

Image: The technology has the unique ability to detect challenging RhD variants that are typically excluded by other commercial tests (Photo courtesy of BillionToOne)

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more

Immunology

view channel

Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel

Image: The LIAISON PLEX® Gram-Positive Blood Culture Assay runs on the on the LIAISON PLEX instrument (Photo courtesy of Diasorin)

Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection

Each year, around 250,000 individuals in the US are diagnosed with bloodstream infections (BSIs). Sepsis caused by these infections carries a mortality rate ranging from 16% to 40%, and any delay in administering... Read more

Image: Cutting-edge hospital genomics initiative takes on dangerous superbug (Photo courtesy of 123RF)

Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections

Superbug infections caused by Staphylococcus aureus, or ‘golden staph’, are notoriously difficult to treat and claim over one million lives globally each year. These bacteria can rapidly develop resistance... Read more

Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria

Colorectal cancer remains one of the deadliest and most common forms of cancer worldwide, with only 40% of cases diagnosed before metastasis. Current screening methods, like colonoscopy, are invasive and... Read more

Image: PowerBlade is a portable device that uses a drop of blood and an automated sequence of steps to efficiently detect sepsis (Photo courtesy of NRC)

Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy

Sepsis is a severe response to an infection that causes the immune system to attack the body's own organs and tissues, potentially leading to organ failure and death if not addressed promptly.... Read more

Pathology

view channel

Image: The AI model compares the epigenetic data of unknown tumors to the fingerprints of over 8,000 reference tumors (Photo courtesy of Philipp Euskirchen/Charité)

AI Model Detects More Than 170 Cancer Types

Diagnosing brain tumors can be especially difficult when the tumor is located in a region where biopsies pose high risks. In such scenarios, where obtaining tissue samples is not feasible, conventional... Read more

Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Image: A new at-home self-collection device aims to reduce the screening gap for cervical cancer (Photo courtesy of CU School of Medicine)

New At-Home Cervical Cancer Screening Device to Increase Accessibility for Patients

Cervical cancer is typically linked to certain types of human papillomavirus (HPV), which is passed through sexual contact. While many people are infected with HPV, only a small percentage will develop... Read more

Technology

view channel

Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more

Image: The second-generation sampler currently under development (Photo courtesy of Breathe BioMedical)

Breath Test to Enable Early Detection of Breast Cancer

Mammograms often fail to detect breast cancer in women with dense breast tissue, missing up to 60% of cases due to reduced image clarity. Breath analytics has the potential to allow for timely detection... Read more

Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more

Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more

Industry

view channel

Image: The collaboration aims to speed up the adoption of ultrasensitive immunoassays incorporating single-molecule counting technology (Photo courtesy of Fujirebio)

Fujirebio Collaborates with Stanford Medicine to Advance Infectious Disease Research

Fujirebio (Tokyo, Japan) has entered into a collaboration with Stanford Medicine (Palo Alto, CA, USA) to accelerate the adoption of ultrasensitive immunoassays that incorporate single-molecule counting... Read more

Image: The LEX system brings together high speed and high sensitivity in a PCR molecular system to redefine POC diagnostics (Photo courtesy of LEX Diagnostics)

QuidelOrtho to Acquire MDx Company LEX Diagnostics

QuidelOrtho Corporation (San Diego, CA, USA) has announced a refocusing of its molecular diagnostics strategy which now includes acquiring LEX Diagnostics (Cambridgeshire, UK) and discontinuing development... Read more

Image: The new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials using QIAcuity digital PCR (Photo courtesy of QIAGEN)

QIAGEN Enters into New Strategic Partnerships for Expanding MRD Testing Portfolio in Oncology

Minimal residual disease (MRD) testing offers a highly sensitive way to monitor treatment response, identify patients at risk of relapse before symptoms appear and inform decisions on therapy usage.... Read more

Danaher and AstraZeneca Partner on Next Generation AI-Powered Diagnostics

Danaher Corporation (Washington, D.C., USA) has entered into a partnership with AstraZeneca (Cambridge, UK to develop and commercialize novel diagnostic tools and tests intended to help clinicians... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2025
MEDLAB 2024
Medica ADLM Medlab 2023
Medica AACC

EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID EUROMEDLAB Medlab 2021
Medica

Copyright © 2000-2025 Globetech Media. All rights reserved.

MOBILE | FULL SITE